EUDA Health Holdings Limited (EUDA)vsJones Lang LaSalle Incorporated (JLL)
EUDA
EUDA Health Holdings Limited
$16.79
+0.38%
REAL ESTATE · Cap: $48.09M
JLL
Jones Lang LaSalle Incorporated
$295.71
-1.11%
REAL ESTATE · Cap: $13.92B
Smart Verdict
WallStSmart Research — data-driven comparison
Jones Lang LaSalle Incorporated generates 392195% more annual revenue ($26.76B vs $6.82M). JLL leads profitability with a 3.4% profit margin vs -40.7%. JLL earns a higher WallStSmart Score of 71/100 (B).
EUDA
Avoid24
out of 100
Grade: F
JLL
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for EUDA.
Margin of Safety
+46.3%
Fair Value
$564.71
Current Price
$295.71
$269.00 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 78.9% year-over-year
Conservative balance sheet, low leverage
Earnings expanding 192.1% YoY
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
3.4% margin — thin
Operating margin of 3.3%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EUDA
The strongest argument for EUDA centers on Revenue Growth, Debt/Equity. Revenue growth of 78.9% demonstrates continued momentum.
Bull Case : JLL
The strongest argument for JLL centers on EPS Growth, Altman Z-Score, PEG Ratio. Revenue growth of 11.1% demonstrates continued momentum. PEG of 0.95 suggests the stock is reasonably priced for its growth.
Bear Case : EUDA
The primary concerns for EUDA are EPS Growth, Market Cap, Return on Equity.
Bear Case : JLL
The primary concerns for JLL are Profit Margin, Operating Margin, Free Cash Flow. Thin 3.4% margins leave little buffer for downturns.
Key Dynamics to Monitor
EUDA profiles as a hypergrowth stock while JLL is a value play — different risk/reward profiles.
JLL carries more volatility with a beta of 1.29 — expect wider price swings.
EUDA is growing revenue faster at 78.9% — sustainability is the question.
EUDA generates stronger free cash flow (-3M), providing more financial flexibility.
Bottom Line
JLL scores higher overall (71/100 vs 24/100) and 11.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
EUDA Health Holdings Limited
REAL ESTATE · REAL ESTATE SERVICES · USA
EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies for rare diseases and unmet medical needs. The company utilizes cutting-edge technologies and maintains a strong clinical pipeline, emphasizing supportive care and immune modulation. With a deep commitment to research and development, EUDA is strategically positioned to drive healthcare advancements, improve patient outcomes, and broaden access to vital medical treatments.
Visit Website →Jones Lang LaSalle Incorporated
REAL ESTATE · REAL ESTATE SERVICES · USA
Jones Lang LaSalle Incorporated, a professional services company, provides real estate and investment management services in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Chicago, Illinois.
Compare with Other REAL ESTATE SERVICES Stocks
Want to dig deeper into these stocks?